A number of Orders in Council dated 31 August 2017 confirm that many provisions of the Canada–European Union Comprehensive Economic and Trade Agreement Implementation Act (commonly referred to as “CETA”) will come into force 21 September 2017. Of note, these provisions include changes to the Patent Rules and the Patented Medicines (Notice of Compliance) Regulations . Proposed amendments to the Patented Medicines (Notice of Compliance) Regulations are further discussed here.
NOT LEGAL ADVICE.
Information made available on this website in any form is for information purposes only. It is not, and should not be taken as legal advice. You should not rely on, or take or fail to take any action, based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Oyen Wiggs Green & Mutala LLP professionals will be pleased to discuss resolutions to specific legal concerns you may have.
Keep up to date on the latest Intellectual Property
news and trends from Oyen Wiggs.
The printing of email addresses on our website does not constitute implied consent to receive unsolicited spam emails. Such emails may be reported to the CRTC under Canada's anti-spam laws.
© 2024 Oyen Wiggs | Canadian Intellectual Property Lawyers | Terms & Conditions | Privacy Policy | A top Legal Industry website & SEO by fSquared Marketing. Serving the legal industry since 2012.